S. C. Remick

548 total citations
28 papers, 421 citations indexed

About

S. C. Remick is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, S. C. Remick has authored 28 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 10 papers in Pathology and Forensic Medicine and 9 papers in Genetics. Recurrent topics in S. C. Remick's work include Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Viral-associated cancers and disorders (8 papers). S. C. Remick is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Viral-associated cancers and disorders (8 papers). S. C. Remick collaborates with scholars based in United States, Kenya and Uganda. S. C. Remick's co-authors include Merrill J. Egorin, Tony Cheung, Bruce J. Dezube, D L Trump, Alan Forrest, K D Tutsch, James K. V. Willson, S. Shriver, Parkash S. Gill and Jamie H. Von Roenn and has published in prestigious journals such as Journal of Clinical Oncology, Antiviral Research and East African Medical Journal.

In The Last Decade

S. C. Remick

27 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. C. Remick United States	9	244	145	76	72	56	28	421
Yasuhiro Arakawa Japan	11	159 0.7×	150 1.0×	86 1.1×	22 0.3×	94 1.7×	37	380
Paloma Martín-Martorell Spain	11	279 1.1×	82 0.6×	190 2.5×	37 0.5×	52 0.9×	30	426
Hari A. Deshpande United States	10	136 0.6×	120 0.8×	90 1.2×	38 0.5×	39 0.7×	46	363
B. Rovati Italy	16	318 1.3×	219 1.5×	76 1.0×	37 0.5×	96 1.7×	38	651
Ji Zhou China	16	292 1.2×	129 0.9×	174 2.3×	72 1.0×	91 1.6×	39	621
Mitsuru Yoshimoto Japan	10	179 0.7×	138 1.0×	31 0.4×	88 1.2×	141 2.5×	37	436
Gregory Pennock United States	8	384 1.6×	113 0.8×	132 1.7×	48 0.7×	34 0.6×	22	527
D.J. Leeming Denmark	9	139 0.6×	138 1.0×	24 0.3×	31 0.4×	50 0.9×	17	404
Satya M. Murthy United States	8	222 0.9×	142 1.0×	141 1.9×	38 0.5×	61 1.1×	12	513
Brian M.J. Cantwell United Kingdom	12	236 1.0×	126 0.9×	83 1.1×	39 0.5×	51 0.9×	21	369

Countries citing papers authored by S. C. Remick

Since Specialization

Citations

This map shows the geographic impact of S. C. Remick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. C. Remick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. C. Remick more than expected).

Fields of papers citing papers by S. C. Remick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. C. Remick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. C. Remick. The network helps show where S. C. Remick may publish in the future.

Co-authorship network of co-authors of S. C. Remick

This figure shows the co-authorship network connecting the top 25 collaborators of S. C. Remick. A scholar is included among the top collaborators of S. C. Remick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. C. Remick. S. C. Remick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sarantopoulos, John, H. J. Lenz, Stephen Shibata, et al.. (2011). Phase I pharmacokinetic study of temsirolimus (CCI-779) in patients with advanced malignancies and normal and impaired liver function: An NCI Organ Dysfunction Working Group (ODWG) study.. Journal of Clinical Oncology. 29(15_suppl). 3072–3072. 6 indexed citations

Sosa, Julie Ann, Rossella Elisei, Barbara Jarząb, et al.. (2011). A randomized phase II/III trial of a tumor vascular disrupting agent fosbretabulin tromethamine (CA4P) with carboplatin (C) and paclitaxel (P) in anaplastic thyroid cancer (ATC): Final survival analysis for the FACT trial.. Journal of Clinical Oncology. 29(15_suppl). 5502–5502. 31 indexed citations

Altaha, Ramin, Gary Marano, Gabriela Hobbs, et al.. (2010). A pilot study of fosbretabulin with bevacizumab in recurrent high-grade gliomas.. Journal of Clinical Oncology. 28(15_suppl). TPS147–TPS147. 2 indexed citations

Cooney, Matthew M., Josep Garcia, Joanna M. Brell, et al.. (2007). A phase I study of bevacizumab in combination with sunitinib in advanced solid tumors. Journal of Clinical Oncology. 25(18_suppl). 15532–15532. 11 indexed citations

Whalen, Christopher, et al.. (2006). Burkitt's lymphoma and emerging therapeutic strategies for EBV and AIDS-associated lymphoproliferative diseases in East Africa. East African Medical Journal. 82(9). S133–4. 2 indexed citations

Orem, Jackson, et al.. (2006). Clinical characteristics of Burkitt's lymphoma from three regions in Kenya. East African Medical Journal. 82(9). S135–43. 8 indexed citations

Orem, Jackson, et al.. (2006). Oral combination chemotherapy in the treatment of AIDS - associated Hodgkin's disease. East African Medical Journal. 82(9). S144–9. 4 indexed citations

Egorin, Merrill J., Chandra P. Belani, S. C. Remick, et al.. (2006). Phase I, pharmacokinetic (PK), & pharmacodynamic (PD) study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, (17DMAG, NSC 707545) in patients with advanced solid tumors. Journal of Clinical Oncology. 24(18_suppl). 3021–3021. 1 indexed citations

Savvides, P., Matthew M. Cooney, Nitin A. Pagedar, et al.. (2006). S070 Phase 2 Study of Combretastatin A4 Phosphate (CA4P) in Patients With Advanced Anaplastic Thyroid Carcinoma (ATC). Archives of Otolaryngology - Head and Neck Surgery. 132(8). 854–854. 2 indexed citations

10.

Savvides, P., J.F. Greskovich, Athanassios Argiris, et al.. (2006). Phase I study of the EGFR tyrosine kinase inhibitor erlotinib in combination with docetaxel and radiation in locally advanced squamous cell cancer of the head and neck (SCCHN). Journal of Clinical Oncology. 24(18_suppl). 5545–5545. 22 indexed citations

11.

Mwanda, Walter, Jackson Orem, Peifen Fu, et al.. (2006). Dose-modified oral chemotherapy for AIDS-related non-Hodgkin’s lymphoma (AR-NHL) in East Africa. Journal of Clinical Oncology. 24(18_suppl). 7564–7564.

12.

Savvides, P., Sanjiv S. Agarwala, J.F. Greskovich, et al.. (2006). P001 Phase 1 Study of Erlotinib, Docetaxel, and Radiation in Locally Advanced Squamous Cell Cancer of the Head and Neck. Archives of Otolaryngology - Head and Neck Surgery. 132(8). 865–865. 1 indexed citations

13.

Lazarus, Hillard M., Brenda Cooper, S L Gerson, et al.. (2005). A phase I trial of bortezomib in combination with fludarabine in patients with lymphoproliferative neoplasms. Journal of Clinical Oncology. 23(16_suppl). 6647–6647. 3 indexed citations

14.

Remick, S. C., et al.. (2003). HIV related malignancies in Kenya. 1 indexed citations

15.

Cheung, Tony, S. C. Remick, N. Azarnia, et al.. (1999). AIDS-related Kaposi's sarcoma: a phase II study of liposomal doxorubicin. The TLC D-99 Study Group.. PubMed. 5(11). 3432–7. 23 indexed citations

16.

Dezube, Bruce J., Jamie H. Von Roenn, Jeanne Holden‐Wiltse, et al.. (1998). Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team.. Journal of Clinical Oncology. 16(4). 1444–1449. 109 indexed citations

17.

Cheung, Tony, et al.. (1998). PHASE II STUDY OF LIPOSOMAL DOXORUBICIN (TLC D-99) IN THE TREATMENT OF AIDS-RELATED KAPOSI'S SARCOMA (KS).. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 17(4). A16–A16. 2 indexed citations

18.

Roenn, Jamie H. Von, S. C. Remick, Timothy P. Cooley, et al.. (1997). FUMAGILLIN ANALOG (TNP-470) IN THE TREATMENT OF KAPOSI'S SARCOMA. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 14(4). A35–A35. 5 indexed citations

19.

Sharp, Victoria, et al.. (1994). Prisoners' access to HIV experimental trials: legal, ethical, and practical considerations.. PubMed. 7(10). 1086–94. 4 indexed citations

20.

Trump, D L, Merrill J. Egorin, Alan Forrest, et al.. (1991). Pharmacokinetic and pharmacodynamic analysis of fluorouracil during 72-hour continuous infusion with and without dipyridamole.. Journal of Clinical Oncology. 9(11). 2027–2035. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact